Chiesi ups its focus on rare diseasesItaly’s Chiesi has created a new business unit aimed at increasing its presence in the market for rare Share XChiesi ups its focus on rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/chiesi-ups-its-focus-on-rare-diseases/
How behavioural science is helping in the fight against COVID-19Thanks to COVID-19, just about every form of media we consume right now is focused on aspects of Share XHow behavioural science is helping in the fight against COVID-19https://pharmaphorum.com/views-analysis-patients/how-behavioural-science-is-helping-in-the-fight-against-covid-19/
What can Linux and Mozilla teach ICER about how to do drug value assessments?The Institute for Clinical and Economic Review (ICER) measures the value of new drugs and health technologies, but Share XWhat can Linux and Mozilla teach ICER about how to do drug value assessments?https://pharmaphorum.com/views-analysis-market-access/what-can-linux-and-mozilla-teach-icer-about-how-to-do-drug-value-assessments/
Coronavirus pharma news roundup – 03/04/20After pharma ramped up its response to coronavirus last week, we heard more this week about the many Share XCoronavirus pharma news roundup – 03/04/20https://pharmaphorum.com/views-analysis-digital/coronavirus-pharma-news-roundup-03-04-20/
AstraZeneca on expanding its diabetes research franchiseAstraZeneca is hoping to build a strong focus on cardiovascular, renal, and metabolic (CVRM) diseases. Richard Staines spoke Share XAstraZeneca on expanding its diabetes research franchisehttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/astrazeneca-takes-on-cvrm/
Eisai and Alexa skills in epilepsy: the pharmaphorum podcastVoice technology like Amazon’s Alexa is taking some big steps forward in healthcare and in the pharmaceutical world Share XEisai and Alexa skills in epilepsy: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/eisai-alexa-skills-epilepsy/
AI and cancer care: 3 ways artificial intelligence may transform cancer outcomesArtificial intelligence (AI) and machine learning (ML) are transforming the way cancers are detected and staged, offering new Share XAI and cancer care: 3 ways artificial intelligence may transform cancer outcomeshttps://pharmaphorum.com/views-analysis-digital/ai-cancer-care-3-ways-artificial-intelligence-transform-cancer-outcomes/
Has COVID-19 forever changed the way pharma does business?There’s no doubt that the COVID-19 pandemic has thrust digital engagement into the spotlight for the pharmaceutical industry Share XHas COVID-19 forever changed the way pharma does business?https://pharmaphorum.com/views-and-analysis/has-covid-19-forever-changed-the-way-pharma-does-business/
Why Norgine is embracing AI chatbots for medical informationWhen European pharma company Norgine saw an unmet need in how patients were seeking information on one of Share XWhy Norgine is embracing AI chatbots for medical informationhttps://pharmaphorum.com/views-analysis-digital/norgine-embracing-ai-chatbot/
